Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).

Type III hyperlipoproteinemia is characterized by delayed chylomicron and VLDL remnant catabolism and is associated with homozygosity for the apoE-2 allele. We have identified a kindred in which heterozygosity for an apoE mutant, apoE-1 (Lys146-->Glu), is dominantly associated with the expression of...

Ful tanımlama

Detaylı Bibliyografya

Yayımlandı:	J Clin Invest
Asıl Yazarlar:	Mann, W A, Lohse, P, Gregg, R E, Ronan, R, Hoeg, J M, Zech, L A, Brewer, H B
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Clinical Investigation 1995
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185299/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7635945/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118096
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!